Furthermore, SOX9 levels were found to be higher in cervical cancer cells and tissues that were resistant to cisplatin, and SOX9 promoted the transcription of lncRNA ANXA2P2 by binding to it.190. This evidence concerns the gene SOX9 and cervical cancer.